One of the challenges of contemporary world is the constantly increasing number of infections caused by antibiotic-resistant bacteria. According to the USA Center for Disease Control and Prevention, in the United States every year 23 000 people dye from infections caused by antibiotic-resistant bacteria. Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), has emphasized that addressing bacterial resistance to antibiotics is one of the priority areas for WHO. One of the ways to address this problem, as envisaged by the WHO, is to develop and synthesize new antibacterial agents. In this work, new potentially biologically active products of the reactions of 3-[(4-methoxyphenyl)amino]propanehydrazide with acyclic and heterocyclic carbonyl compounds will be synthesized and their antibacterial activity will be investigated.
Project funding:
Project is funded by EU Structural Funds according to the 2014–2020 Operational Programme for the European Union Funds’ Investments priority “Development of scientific competence of researchers, other researchers, students through practical scientific activities” under Measure No. 09.3.3-LMT-K-712.
Project results:
Conference presentation
Period of project implementation: 2018-10-01 - 2019-04-30
Project coordinator: Kaunas University of Technology
